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Preliminary evidence for quality of life improvements after
acceptance and commitment therapy in primary insomnia
E. Hertenstein, N. Thiel, M. Lueking, A. K. Kuelz, E. Schramm, C.
Baglioni, K. Spiegelhalder, D. Riemann and C. Nissen
University Medical Center Freiburg, Freiburg, Germany
Background: Cognitive behavior therapy for insomnia (CBT-I)
improves subjective and objective parameters of sleep in patients
with primary insomnia (PI). However, the perception of poor sleep
and an impaired quality of Life (QoL) often persists despite treatment.
This study aimed to provide ﬁrst evidence that Acceptance and
Commitment Therapy (ACT), an intervention including mindfulness
and value-based changes of behavior, can improve subjective sleep
quality and QoL in patients with chronic PI.
Methods: Eleven patients with chronic PI who were non- or partial
responders to CBT-I were included. Data were collected 6 weeks
prior to the intervention (T!1), directly before (T0) and after the
intervention (T1), and at 3-months follow-up (T2). The intervention
consisted of six ACT sessions in an outpatient group setting. Primary
outcomes were sleep-related QoL (Glasgow Sleep Impact Index),
global QoL (World Health Organization Quality of Life scale) and
subjective sleep quality (measured by sleep diaries).
Results: Ten patients completed the study, one dropped out due to
scheduling problems. All measures remained stable between T!1
and T0. Signiﬁcant improvements after the intervention were
observed for sleep-related QoL, global QoL, and subjective sleep
quality (ANOVA with factor Time, post-hoc contrasts T1 and T2 vs.
T0, all Ps< 0.05, large effect sizes). Subjective total sleep time, sleep
onset latency and wake time after sleep onset did not signiﬁcantly
change across the study.
Conclusions: The ﬁndings provide preliminary evidence that ACT
might improve subjective sleep quality and the QoL in patients with PI.
Disclosure: CN has received speaker honoraria from Servier. DR
has received a consulting fee from Abbvie Germany. The other
authors indicate no ﬁnancial conﬂicts of interest.
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The mediating role of anxiety and depression on the
association between perfectionism, sleep-disturbances, and
insomnia severity
U. Akram, J. G. Ellis, A. Myachykov and N. L. Barclay
Northumbria Centre for Sleep Research, Northumbria University,
Newcastle upon Tyne, United Kingdom
Individuals with sleep-disturbances, speciﬁcally insomnia, often
exhibit aspects of perfectionism, and symptoms of anxiety and
depression, however the investigation of these factors together has
been diminutive. The present study examined the mediating role of
anxiety and depression on the associations between sleep-distur-
bances, insomnia-severity and aspects of perfectionism.
Eighty six participants (Age: M = 25, SD = 10.02; 80% female) were
assessed using the Pittsburgh Sleep Quality Index (PSQI) and
Insomnia Severity Index (ISI). Participants also completed two
Multidimensional Perfectionism Scales (F-MPS; HF-MPS), and the
Hospital Anxiety and Depression Scale (HADS).
Poor-sleepers demonstrated signiﬁcantly higher scores on the F-
MPS subscale doubts-about-action compared to normal-sleepers (t
(84) = 2.54, P = 0.01). Additionally, global PSQI scores were signif-
icantly associated with doubts-about-action (r = 0.22, P = 0.04).
Insomnia-severity was signiﬁcantly associated with the F-MPS
subscales of doubts-about-action (r = 0.32, P = 0.01), concern-
over-mistakes (r = 0.26, P = 0.02), and parental-criticism (r = 0.30,
P = 0.01). Hierarchal multiple-regression analyses, separately exam-
ining the global PSQI and insomnia-severity scores, demonstrated
that when anxiety and depression were controlled for, none of the
previous associations remained signiﬁcant.
The results indicate that:
1. both increased sleep-disturbance and insomnia severity appear to
be associated with increased doubts-about-action;
2. increased insomnia-severity also appears to be associated with
increased concern-over-mistakes, and parental criticism; and
3. these associations are mediated by anxiety and depression.
These results could suggest that treatments for sleep-disturbance
and insomnia should address anxiety and depressive symptoms,
with the prospect of alleviating aspects of perfectionism, speciﬁcally
doubts-about-action, concern-over-mistakes, and parental criticism,
that may perpetuate pre-sleep arousal, consequently disturbing
sleep.
Disclosure: Nothing to disclose.
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Sublingual ﬂumazenil for the residual effects of hypnotics:
zolpidem and brotizolam
N. Katz1, G. Pillar2, E. Peled2 and N. Peled3
1NICU, Walfson Medical Center, Holon, 2Technion Faculty of
Medicine, Haifa, 3Tel Aviv University Faculty of Medicine, Hod
Hasharon, Israel
Background: Residual morning drowsiness is a frequent side effect
of hypnotics which limits optimal treatment in Insomnia.
Purpose: To study the safety and efﬁcacy of sublingual Flumazenil
(GABA-A antidote) in reversing the residual hypnotic effect.
Methods: A double blind, placebo controlled, randomized cross over
study with twenty healthy subjects who slept for 1.5 h following sleep
induction (Zolpidem n = 10; Brotizolam n = 10). Upon awakening,
they underwent neurocognitive tests including immediate word recall
test (iWRT), Digit Symbol Substitution Test (DSST), and mood/
performance questionnaires. They were then treated by Flumazenil
or placebo (n = 20;20) and were re-evaluated after 20 and 60 min. A
week later, the same procedures were performed (Placebo/Flumaze-
nil accordingly).
Results: All 20 volunteers completed the study. Flumazenil was
superior to placebo by 59–93% (P < 0.05–0.001) in improving
performance in the various neurocognitive tasks. Subjects reported
a signiﬁcant improvement in vigilance with Flumazenil, both at 20 min
(3.0 " 0.6 cm vs. 1.3 " 0.6 cm, P < 0.02) and 60 min
(4.7 " 0.6 cm vs. 2.8 " 0.7 cm, P < 0.03). iWRT improved with
Flumazenil vs. placebo at 20 min (4.2 " 0.8 vs. 1.3 " 0.9 words,
P < 0.005) and 60 min (5.4 " 1.1 vs. 1.2 " 1.2 words, P < 0.02).
Conclusions: Sublingual administration of Flumazenil is safe and
effective in reversing the hypnotic effects of Zolpidem and Brotizo-
lam. This may offer a comprehensive and safer treatment for
insomniac patients.
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